#HoroscopeDuJour #Astro2025 #Horoscope30Decembre #Zodiaque #AstroQuotidien presse83.fr/2025/12/30/h...
#HoroscopeDuJour #Astro2025 #Horoscope29Decembre #ZodiaqueQuotidien #AstroDuJour presse83.fr/2025/12/29/h...
#HoroscopeDuJour #Astro2025 #Horoscope28Decembre #Zodiaque #AstroDuJour presse83.fr/2025/12/28/h...
#HoroscopeDuJour #Astro2025 #Horoscope27Decembre #SignesZodiaque #AstroQuotidien presse83.fr/2025/12/27/h...
#HoroscopeDuJour #Astro2025 #Horoscope26Decembre #LunePoissons #AstroGratuit presse83.fr/2025/12/26/h...
#Horoscope #Astrologie #SignesDuZodiaque #HoroscopeDuJour #Astro2025 presse83.fr/2025/10/29/h...
🌟 Markey researchers are pushing the boundaries of #RadiationOncology
At #ASTRO2025, our team presented studies advancing treatment precision, equity & outcomes, from lung & breast cancer to rural oncology care.
Learn more ⤵️
🔗 https://bit.ly/4opNmJq
#UKMarkey
TTFields treatment following stereotactic radiosurgery prolonged the time to intracranial progression for patients with brain metastases from NSCLC, according to research presented at #ASTRO25 by Dr Vinai Gondi.
shorturl.at/cIx6O
#lcsm #NSCLC #ASTRO2025
In men with prostate cancer, prophylactic whole pelvic radiotherapy does not improve OS compared to prostate-only dose-escalated radiotherapy. Presented at #ASTRO25 by Dr Mack Roach of @ucsfradonc.bsky.social.
shorturl.at/GWacU
#pcsm #gucsm #ASTRO2025
Recurrent prostate cancer patients with luminal B tumors may benefit from hormone therapy added to radiation following surgery, according to research presented at #ASTRO25.
shorturl.at/BF1EP
#pcsm #gucsm #ASTRO2025
A single course of low-dose radiation therapy led to significant reductions in pain and improvements in physical function in mild-to-moderate knee osteoarthritis, a randomized trial from South Korea showed. #ASTRO2025
www.medpagetoday.com/meetingcover...
Prophylactic whole-pelvic radiation therapy (RT) did not perform as expected for patients with unfavorable intermediate-risk or favorable high-risk prostate cancer, according to interim results from a large randomized trial. #ASTRO2025
www.medpagetoday.com/meetingcover...
Adjuvant radiotherapy improves locoregional failure-free survival, compared with observation, in patients with locally advanced MIBC, according to research presented at #ASTRO25. #blcsm #gucsm #astro2025
shorturl.at/kWlRH
“For patients who do not respond to traditional therapies and are at high risk of complications, noninvasive radiation may be a safer alternative.”
🔗 https://ow.ly/bNsx50X5naR
#ASTRO25 #ASTRO2025 #RadOnc #RadiationTherapy
“This needs to be a multinational effort and requires considerable funding, so there is a lot of work to be done,” Dr. Siva said.
🔗 https://ow.ly/UwiX50X5n9p
#ASTRO #ASTRO25 #ASTRO2025 #RadOnc
Had a fantastic time at #ASTRO2025 in San Francisco - grateful for the chance to reconnect with colleagues, collaborators, and friends from around the world! @astro-org.bsky.social @ucsfradonc.bsky.social @ruehlealex.bsky.social
"The results help clarify what patients can expect from shorter versus longer courses of radiation therapy and enable more personalized treatment decisions."
🔗 https://ow.ly/KVZQ50X4BfJ
#ASTRO25 #ASTRO2025 #RadOnc
Treatment with intensity-modulated proton therapy or intensity-modulated radiation therapy resulted in similarly low rates of late toxicity in patients with locally advanced oropharyngeal cancer, a randomized trial showed. #ASTRO2025
www.medpagetoday.com/meetingcoverage/astro/11...
Missing #ASTRO2025? We've got you covered.
Check out our reporting from this year's American Society for Radiation Oncology meeting ⬇️
Radiation therapy after surgery for high-risk muscle-invasive bladder cancer significantly reduced the rate of local recurrence and improved survival, according to a randomized trial from India. #ASTRO2025
www.medpagetoday.com/meetingcoverage/astro/11...
More than half of patients with higher-risk rectal cancer avoided aggressive surgery for at least 2 years following short-course radiation therapy and chemotherapy consolidation, a prospective study showed. #ASTRO2025
www.medpagetoday.com/meetingcoverage/astro/11...
“Our results confirm that high-quality IMRT is a very good treatment for this disease.”
🔗 https://ow.ly/sNuz50X4B7k
#ASTRO25 #ASTRO2025 #RadOnc
“This is one of the first and largest randomized trials to show that post-operative radiation therapy can meaningfully reduce pelvic relapses in bladder cancer,” said Vedang Murthy, MD
🔗 https://ow.ly/jcrM50X44Sf
#ASTRO25 #ASTRO2025 #RadOnc #BladderCancer
For patients with recurrent prostate cancer, those with a certain subtype had clinically meaningful benefits when apalutamide (Erleada) was added to salvage radiotherapy after radical prostatectomy, a randomized trial showed. #ASTRO2025
www.medpagetoday.com/meetingcoverage/astro/11...
“This study represents an important contribution to our understanding of what is happening during prostate cancer radiation and how we can preserve a man’s quality of life after treatment.”
🔗 https://ow.ly/nbfi50X44Ht
#ASTRO25 #ASTRO2025
“Patients should feel reassured that they can receive high-quality care with either photon or proton therapy,” said Shannon MacDonald, MD
🔗 https://ow.ly/uWgX50X44Wu
#ASTRO25 #ASTRO2025 #RadOnc #BreastCancer
“With Rembra RT and Areta RT, we’re once again setting new standards in radiation therapy, empowering care teams with the precision, dependability, and speed they need to deliver the best outcomes,” said Dan Xu.
🔗 https://ow.ly/9exE50X3nwj
#ASTRO25 #ASTRO2025
“With Rembra RT and Areta RT, we’re once again setting new standards in radiation therapy, empowering care teams with the precision, dependability, and speed they need to deliver the best outcomes,” said Dan Xu.
🔗 https://ow.ly/9exE50X3nwj
#ASTRO25 #ASTRO2025
Issue #742 of The Imaging Wire is live:
- Does BMI Affect AI Accuracy?
- U.S. Probes Medical Device Imports
- Radiation Oncology Highlights at #ASTRO25
- Why AI Isn’t Replacing Radiologists
Check it out at theimagingwire.com/newsletter/b....
#radiology #cancer #RadOnc #ASTRO2025
“We’ve been searching for decades for a way to determine which patients are most likely to respond to hormone therapy after prostatectomy,” said Daniel Spratt, MD
🔗 Read more from the News page on our website (link in bio)!
#ASTRO25 #ASTRO2025